Candriam Equities L Biotech.C USD Acc/ LU0108459040 /
| NAV2024-04-25 | Chg.-8.9800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 787.3900USD | -1.13% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 | - | - | - | - | 9.07 | 39.65 | -8.01 | 23.69 | 10.72 | -11.24 | -13.74 | 4.18 | - |
| 2001 | -2.63 | -12.28 | -20.64 | 18.86 | 9.28 | 4.98 | -14.90 | 2.77 | -19.22 | 16.98 | 9.78 | 0.03 | -16.11% |
| 2002 | -15.77 | -3.67 | 2.35 | -17.67 | 0.37 | -18.94 | 1.98 | 0.98 | -9.51 | 9.49 | 7.68 | -10.47 | -45.29% |
| 2003 | -0.87 | -4.59 | 6.07 | 7.14 | 19.99 | -3.00 | 7.99 | -2.86 | 2.19 | 2.19 | -1.66 | 6.66 | +43.75% |
| 2004 | 7.07 | 1.56 | -1.42 | -0.38 | -2.52 | -0.01 | -9.08 | 2.22 | 5.80 | -2.11 | 0.82 | 6.15 | +7.21% |
| 2005 | -3.81 | -5.19 | -3.97 | 3.02 | 6.36 | 2.85 | 10.12 | 1.25 | 2.79 | -3.40 | 5.66 | 1.29 | +16.93% |
| 2006 | 6.13 | 3.96 | -3.54 | -4.77 | -4.44 | 0.11 | -2.51 | 2.57 | 0.18 | 13.74 | 0.76 | -2.27 | +8.79% |
| 2007 | 2.29 | -3.54 | 2.03 | 7.46 | 0.08 | -5.87 | -2.83 | 1.88 | 5.51 | 2.14 | -2.82 | -5.95 | -0.63% |
| 2008 | -5.04 | -3.45 | 1.53 | 1.41 | 1.64 | -2.69 | 17.01 | -4.26 | -6.57 | -15.64 | -10.17 | 8.05 | -19.99% |
| 2009 | -1.37 | -7.11 | 6.21 | -0.50 | 2.87 | 7.09 | 29.17 | 2.60 | 1.37 | -11.25 | 7.99 | 5.19 | +44.45% |
| 2010 | 3.27 | 6.33 | 14.95 | -2.01 | -12.51 | -5.72 | 3.61 | -0.48 | 10.71 | 2.67 | -2.59 | 6.17 | +23.66% |
| 2011 | -0.63 | 0.72 | 5.91 | 4.53 | 2.94 | -1.78 | -3.57 | -8.01 | -6.69 | 7.93 | 0.69 | 1.78 | +2.57% |
| 2012 | 11.82 | 0.38 | 5.76 | 0.55 | -2.15 | 5.51 | 2.34 | 1.91 | 5.14 | -5.96 | 4.39 | -1.04 | +31.27% |
| 2013 | 9.67 | 1.01 | 8.08 | 6.09 | 3.28 | -2.75 | 14.25 | -2.44 | 9.94 | -2.80 | 6.53 | 1.61 | +64.48% |
| 2014 | 8.25 | 7.34 | -9.94 | -5.09 | 2.76 | 10.11 | -3.25 | 11.06 | -1.11 | 9.59 | 2.98 | 0.58 | +35.53% |
| 2015 | 4.47 | 4.53 | 1.86 | -5.10 | 10.73 | 0.63 | 4.16 | -10.95 | -11.39 | 7.80 | 3.42 | 0.32 | +8.14% |
| 2016 | -23.24 | -4.59 | 3.68 | 3.69 | 5.59 | -8.41 | 12.56 | -2.39 | 3.97 | -12.73 | 9.11 | -2.84 | -19.53% |
| 2017 | 5.50 | 6.84 | 0.08 | 1.07 | -2.95 | 9.37 | 2.39 | 6.82 | 0.89 | -6.61 | 0.13 | 1.45 | +26.68% |
| 2018 | 6.69 | -4.62 | -2.14 | -3.21 | 4.60 | 0.80 | 4.40 | 4.12 | -2.09 | -14.02 | 4.12 | -8.32 | -11.23% |
| 2019 | 13.12 | 3.56 | -0.57 | -4.95 | -4.48 | 9.42 | -2.21 | -2.37 | -4.52 | 11.18 | 11.96 | 2.77 | +34.96% |
| 2020 | -5.28 | -1.53 | -4.99 | 12.35 | 9.48 | 1.27 | -3.02 | 0.83 | 0.71 | -2.66 | 9.44 | 2.97 | +19.24% |
| 2021 | 1.80 | -2.60 | -4.29 | 2.71 | -2.27 | 6.34 | -1.47 | 3.88 | -4.25 | 0.15 | -4.39 | 2.40 | -2.66% |
| 2022 | -10.59 | -1.56 | 6.03 | -7.24 | -3.98 | 3.50 | 4.70 | 1.52 | -1.91 | 6.49 | 6.17 | -2.87 | -1.49% |
| 2023 | 2.90 | -5.67 | 0.23 | 2.26 | -0.95 | 1.42 | -0.59 | -0.24 | -4.49 | -6.13 | 6.15 | 13.62 | +7.16% |
| 2024 | 1.48 | 1.34 | -0.04 | -7.40 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.79% | 18.53% | 16.14% | 20.11% | 22.71% |
| Sharpe ratio | -1.17 | 1.34 | -0.12 | -0.21 | 0.15 |
| Best month | +13.62% | +13.62% | +13.62% | +13.62% | +13.62% |
| Worst month | -7.40% | -7.40% | -7.40% | -10.59% | -10.59% |
| Maximum loss | -11.05% | -11.05% | -15.78% | -28.86% | -30.62% |
| Outperformance | -4.39% | - | -5.62% | +0.32% | -4.76% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,921.4600 | +2.25% | -0.61% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 208.1400 | +4.41% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,926.8199 | -0.03% | -7.54% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,092.0100 | +4.68% | +11.74% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,227.6599 | +1.41% | +9.02% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 339.6200 | +2.10% | +12.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 306.8900 | +5.38% | +14.35% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 188.5900 | -1.74% | -8.61% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,723.8101 | +3.10% | +2.15% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 140.0100 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 561.0800 | +1.57% | -2.32% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,257.0898 | +2.13% | -0.98% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 184.9100 | -0.21% | -7.67% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 192.7000 | +0.65% | -5.40% | |
| Candriam Equities L Biotech.R US... | reinvestment | 249.9000 | +2.84% | +1.38% | |
| Candriam Equities L Biotech.C US... | reinvestment | 787.3900 | +1.95% | -1.07% | |
| Candriam Equities L Biotech.C US... | paying dividend | 723.3100 | +1.92% | -1.17% |
Performance
| YTD | -4.82% | ||
|---|---|---|---|
| 6 Months | +13.39% | ||
| 1 Year | +1.95% | ||
| 3 Years | -1.07% | ||
| 5 Years | +41.53% | ||
| Since start | +687.39% | ||
| Year | |||
| 2023 | +7.16% | ||
| 2022 | -1.49% | ||
| 2021 | -2.66% | ||
| 2020 | +19.24% | ||
| 2019 | +34.96% | ||
| 2018 | -11.23% | ||
| 2017 | +26.68% | ||
| 2016 | -19.53% | ||
| 2015 | +8.14% | ||
